Si-Ahmed SN - Search Results

1

FIG4 is a hepatitis C virus particle-bound protein implicated in virion morphogenesis and infectivity with cholesteryl ester modulation potential.

Cottarel J, Plissonnier ML, Kullolli M, Pitteri S, Clément S, Millarte V, Si-Ahmed SN, Farhan H, Zoulim F, Parent R. Cottarel J, et al. J Gen Virol. 2016 Jan;97(1):69-81. doi: 10.1099/jgv.0.000331. Epub 2015 Oct 29. J Gen Virol. 2016. PMID: 26519381

2

Pathobiology of HBV mutants and clinical impact for treatment monitoring.

Si Ahmed SN, Zoulim F. Si Ahmed SN, et al. Expert Rev Anti Infect Ther. 2009 Apr;7(3):309-20. doi: 10.1586/eri.09.10. Expert Rev Anti Infect Ther. 2009. PMID: 19344244 Review.

3

Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study.

Si-Ahmed SN, Pradat P, Zoutendijk R, Buti M, Mallet V, Cruiziat C, Deterding K, Dumortier J, Bailly F, Esteban R, Wedemeyer H, Janssen HL, Zoulim F. Si-Ahmed SN, et al. Antiviral Res. 2011 Oct;92(1):90-5. doi: 10.1016/j.antiviral.2011.07.003. Epub 2011 Jul 13. Antiviral Res. 2011. PMID: 21767570 Clinical Trial.

4

Impact of lamivudine-resistance mutations on entecavir treatment outcome in hepatitis B.

Koffi J, Egounlety R, Pradat P, Lebosse F, Si-Ahmed SN, Lussier V, Chevallier P, Bailly F, Zoulim F. Koffi J, et al. Eur J Gastroenterol Hepatol. 2014 Feb;26(2):146-54. doi: 10.1097/MEG.0b013e328365c3e5. Eur J Gastroenterol Hepatol. 2014. PMID: 24025974

5

Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.

Trabaud MA, Bailly F, Si-Ahmed SN, Chevallier P, Sepetjan M, Colucci G, Trépo C. Trabaud MA, et al. J Med Virol. 1997 May;52(1):105-12. J Med Virol. 1997. PMID: 9131466

6

Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort).

Barré T, Pol S, Ramier C, Di Beo V, Carrat F, Bureau M, Bourlière M, Dorival C, Serfaty L, Asselah T, Boursier J, Marcellin F, Carrieri P, Fontaine H, Protopopescu C; ANRS/AFEF Hepather Study Group. Barré T, et al. Cannabis Cannabinoid Res. 2022 Oct;7(5):677-689. doi: 10.1089/can.2021.0094. Epub 2021 Oct 13. Cannabis Cannabinoid Res. 2022. PMID: 34648718 Free PMC article.

7

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis.

Nahon P, Najean M, Layese R, Zarca K, Segar LB, Cagnot C, Ganne-Carrié N, N'Kontchou G, Pol S, Chaffaut C, Carrat F, Ronot M, Audureau E, Durand-Zaleski I; ANRS CO12 CirVir; ANRS CO22 Hepather; Scientific Committee – Voting members; CIRRAL groups. Nahon P, et al. JHEP Rep. 2021 Nov 4;4(1):100390. doi: 10.1016/j.jhepr.2021.100390. eCollection 2022 Jan. JHEP Rep. 2021. PMID: 34977518 Free PMC article.

8

Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI).

Maynard M, Pradat P, Bailly F, Rozier F, Nemoz C, Si Ahmed SN, Adeleine P, Trépo C; French Multicenter Group. Maynard M, et al. J Hepatol. 2006 Mar;44(3):484-90. doi: 10.1016/j.jhep.2005.11.038. Epub 2005 Dec 20. J Hepatol. 2006. PMID: 16426697 Clinical Trial.

9

Uncommon side-effects of interferon.

Bailly F, Mattei A, SiAhmed SN, Trepo C. Bailly F, et al. J Viral Hepat. 1997;4 Suppl 1:89-94. doi: 10.1111/j.1365-2893.1997.tb00167.x. J Viral Hepat. 1997. PMID: 9097285

10

Pol S; ANRS/AFEF study group. Pol S, et al. Aliment Pharmacol Ther. 2021 Mar;53(5):616-629. doi: 10.1111/apt.16197. Epub 2021 Jan 19. Aliment Pharmacol Ther. 2021. PMID: 33464621 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page